To clarify the mechanism leading to the development and rupture of intracranial aneurysms, tensile strength and viscoelastic parameters of 22 human saccular aneurysms were investigated. Meridional and circumferential strips from the thin and the thick part of the aneurysm sack and 18 control strips from the basilar artery of 8 patients with pathologies not affecting the cerebral arterial system were studied. The length of the strips was increased in 200-µm steps, while distending force was recorded. Tensile strength and viscoelastic parameters were computed. In both directions, tensile strength of thick strips was significantly lower than that of controls. In the meridional direction, tensile strength of thin strips was significantly larger than that of thick ones (14.5 ± 4.1 × 106 vs. 7.5 ± 2.0 × 106 dyn/cm2, p < 0.05). In the circumferential direction, thin strips tore at lower strain values than thick ones (29 ± 4 vs. 55 ± 16%, p < 0.05). Viscoelastic parameters changed in parallel. In circumferential direction, values of thick and thin strips were significantly lower than those of controls. In the meridional direction, values of thin strips were significantly higher than those of the thick ones. These observations show that characteristic mechanical deterioration and steric inhomogeneities accompany the loss of smooth muscle cells and the derangement of connective tissue elements in the wall of intracranial aneurysms, which may explain certain steps in their initiation, enlargement and rupture.

1.
Hademenos GJ: Neuroangiographic assessment of aneurysm stability and impending rupture based on a non-linear biomathematical model. Neurol Res 1995;17:113–119.
2.
Hademenos GJ, Massoud T, Valentino DJ, Duckwiler G, Vinuela F: A nonlinear mathematical model for the development and rupture of intracranial saccular aneurysms. Neurol Res 1994;16:376–384.
3.
Scott S, Ferguson GG, Roach MR: Comparison of the elastic properties of human intracranial arteries and aneurysms. Can J Physiol Pharmacol 1972;50:328–332.
4.
Steiger HJ, Aaslid R, Reulen HJ: Growth of aneurysms can be understood as passive yield to blood pressure. Acta Neurochir (Wien) 1989;100:74–78.
5.
Nakatani H, Hashimoto N, Kang Y, Yamazoe N, Kikuchi H, Yamaguchi S, Niimi H: Cerebral blood flow patterns at major vessel bifurcations and aneurysms in rats. J Neurosurg 1991;74:258–262.
6.
Steiger HJ: Pathophysiology of development and rupture of cerebral aneurysms. Acta Neurochir Suppl (Wien) 1990;48:1–57.
7.
Dobrin PB, Anidjar S: Pathophysiology of arterial aneurysms. Arch Mal Cœur Vaiss 1991;84:557–562.
8.
Hegedûs K: Some observations on reticular fibers in the media of the major cerebral arteries. A comparative study of patients without vascular disease and those with ruptured berry aneurysms. Surg Neurol 1984;22:301–307.
9.
Pope FM: Type III collagen mutations and cerebral aneurysms. Stroke 1989;20:1432–1433.
10.
Gao YZ, van-Alphen HA: Pathogenesis and histopathology of saccular aneurysms (review). Neurol Res 1990;12:249–255.
11.
Rossitti S, Lofgren J: Vascular dimensions of the cerebral arteries follow the principle of minimum work. Stroke 1993;24:371–377.
12.
Jain KK: Mechanism of rupture of intracranial saccular aneurysms. Surgery 1963;54:347–350.
13.
Yong-Zhong G, van Alphen HAM: Pathogenesis and histopathology of saccular aneurysms: Review of the literature. Neurol Res 1990;12:249–255.
14.
Ostergaard JR, Oxlund H: Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms. J Neurosurg 1987;67:690–696.
15.
Oxlund H: Relationship between the biomechanical properties, composition and molecular structure of connective tissues. Connect Tissue Res 1986;15:65–72.
16.
Monos E, Szücs B: Vascular biomechanical factors in regulation of arterial hemodynamics: Computer models. Acta Physiol Hung 1992;79:3–22.
17.
Gow BS, Hadfield CD: The elasticity of canine and human coronary arteries with reference to postmortem changes. Circ Res 1979;45:588–594.
18.
Crompton MR: The pathogenesis of cerebral aneurysms. Brain 1966;89:797–814.
19.
Dobrin PB, Baker WH, Gley WC: Elastolytic and collagenolytic studies of arteries. Implications for the properties of aneurysms. Arch Surg 1984;119:405–409.
20.
Suzuki J, Ohara H: Clinicopathological study of cerebral aneurysms. J Neurosurg 1978;48:505–514.
21.
Stehbens WE: Ultrastructure of aneurysms. Arch Neurol (Chicago) 1975;32:799–807.
22.
Campbell GJ, Roach MR: A physical model for the formation of evaginations: A prospective precursor to the creation of saccular aneurysms. Stroke 1984;15:642–652.
23.
Kim C, Kikuchi H, Hashimoto N, Kojima M, Kang Y, Hazama F: Involvement of internal elastic lamina in development of induced cerebral aneurysms in rats. Stroke 1988;19:507–511.
24.
Yamazoe N, Hashimoto N, Kikuchi H, Hazama F: Elastic skeleton of intracranial cerebral aneurysms in rats. Stroke 1990;21:1722–1726.
25.
Connolly ES Jr, Fiore AJ, Winfree CJ, Prestigiacoma CJ, Goldman JE, Solomon RA: Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery 1997;40:903–909.
26.
Futami K, Yamashita J, Tachibana O, Higashi S, Ikeda K, Yamashima T: Immunohistochemical alterations of fibronectin during the formation and proliferative repair of experimental cerebral aneurysms in rats. Stroke 1995;26:1659–1664.
27.
Skirgaudas M, Awad IA, Kim J, Rothbart D, Criscuolo G: Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 1996;39:537–545.
28.
Hegedûs K: Ectasia of the basilar artery with special reference to possible pathogenesis. Surg Neurol 1985;24:463–469.
29.
Chyatte D, Reilly J, Tilson MD: Morphometric analysis of reticular and elastin fibers in the cerebral arteries of patients with intracranial aneurysms. Neurosurgery 1990;26:939–943.
30.
Gaetani P, Tartara F, Tancioni F, Rodriguez y Baena R, Casari E, Alfano M, Grazioli V: Deficiency of total collagen content and of deoxypyridinoline in intracranial aneurysm walls. FEBS Lett 1997;404:303–306.
31.
Majamaa K, Myllyla VV: A disorder of collagen biosynthesis in patients with cerebral artery aneurysm. Biochim Biophys Acta 1993;1225:48–52.
32.
Whittaker P, Schwab ME, Canham PB: The molecular organization of collagen in saccular aneurysms assessed by polarized light microscopy. Connect Tissue Res 1988;17:43–54.
33.
Nikkari ST, Javelainen HT, Wight TN, Ferguson M, Clowes AW: Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 1994;144:1348–1356.
34.
Leung DYM, Glagov S, Mathews MB: Elastin and collagen accumulation in rabbit ascending aorta and pulmonary trunk during postnatal growth: Correlation of cellular synthetic response with medial tension. Circ Res 1977;41:316–323.
35.
Birk DE, Zycbaud EI, Winckelmann DA, Trelstad RL: Collagen fibrillogenesis in situ. Discontinuous segmental assembly in extracellular compartments. Ann NY Acad Sci 1990;580:176–194.
36.
Trelstad RL: Matrix macromolecules: Spatial relationships in two dimensions. Ann NY Acad Sci 1990;580:391–420.
37.
Fung YC: Mechanical properties of living tissues; in Fung YC (ed): Biomechanics. New York, Springer, 1981.
38.
Hudetz AG, Monos E: A viscoelastic model of mechanically induced and spontaneous contractions of vascular smooth muscle. Acta Physiol Hung 1985;65:109–123.
39.
Findley WN, Lai JS, Onaran K: Creep and relaxation of nonlinear viscoelastic materials with an introduction to linear viscoelasticity. Amsterdam, North-Holland, 1976.
40.
Monos E, Kovách AGB: Biomechanical properties of splenic artery. Acta Physiol Hung 1980;55:355–364.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.